Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UBS Analyst Maintains Buy Rating and Raises Price Target for Procter Gamble

Elaine Mendonca by Elaine Mendonca
January 24, 2024
in Breaking News
0
Consumer Electronics Trading online
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

On January 24, 2024, UBS analyst Peter Grom expressed his positive outlook on Procter & Gamble (NYSE: PG) by maintaining a Buy rating and increasing the price target to $178. This revised price target aligns with the average projection for Procter & Gamble, which stands at $166.35. Notably, the highest price target set by an analyst for the company’s stock is $178, while the lowest is $138. Over the past year, 18 analysts have weighed in on Procter & Gamble, resulting in a consensus rating of Moderate Buy.

Procter & Gamble (PG) Stock Analysis: Mixed Performance and Potential Recovery

On January 24, 2024, Procter & Gamble (PG) experienced mixed performance in the stock market. Let’s delve into the details and analyze the factors that influenced the stock’s movements.

Price Momentum:
PG’s stock was observed to be trading near the top of its 52-week range, indicating strong performance compared to its historical prices. Additionally, the stock was trading above its 200-day simple moving average, suggesting a positive trend in the long term.

Price Change:
The closing price of PG shares on January 24, 2024, stood at $152.12. However, since the market last closed, the stock experienced a decrease of $1.86, representing a 1.21% drop. This decline in price might have been influenced by various factors such as market sentiment, industry trends, or company-specific news.

After-Hours Trading:
Following the market close, PG’s stock showed a slight recovery in after-hours trading, with an increase of $0.17.

Analyzing the Performance:
Despite the slight decline in price during regular trading hours, the subsequent increase in after-hours trading suggests that investors may have viewed the dip as an opportunity to buy PG shares at a discounted price. This positive sentiment could be attributed to the company’s strong fundamentals, potential growth prospects, or positive news developments.

Conclusion:
On January 24, 2024, Procter & Gamble’s stock performance exhibited a mix of positive and negative movements. While the stock traded near the top of its 52-week range and above its 200-day simple moving average, it experienced a slight decline during regular trading hours. However, the subsequent increase in after-hours trading indicated a potential recovery. Investors should closely monitor market trends, company news, and other relevant factors to make informed decisions regarding PG stock.

Procter & Gamble (PG) Stock Performance Holds Strong Despite Q2 Decline

Title: Procter & Gamble (PG) Stock Performance Remains Steady Despite Q2 Decline

Introduction:
On January 24, 2024, Procter & Gamble (PG) showcased a stable financial performance. This article will delve into PG’s stock performance on January 24, 2024, based on the data provided by CNN Money.

Total Revenue:
Procter & Gamble reported a total revenue of $82.01 billion over the past year, indicating no significant change from the previous year. Similarly, the company’s total revenue held steady at $21.44 billion during Q2.

Net Income:
While the company’s total revenue remained stable, there was a decline in net income. Procter & Gamble recorded a net income of $14.65 billion over the past year, which remained flat compared to the previous year. However, during Q2, the net income experienced a significant decrease of 23.29%, amounting to $3.47 billion.

Earnings per Share:
PG’s earnings per share (EPS) also witnessed a similar trend. With an EPS of $5.90 over the past year, the company managed to maintain its performance at the same level as the previous year. However, during Q2, the EPS experienced a decline of 23.08%, reaching $1.41.

Stock Performance:
Despite the decline in net income and EPS during Q2, Procter & Gamble’s stock performance on January 24, 2024, remained stable. Investors seemed to have confidence in the company’s ability to weather short-term challenges and maintain its market position.

Conclusion:
Procter & Gamble’s stock performance on January 24, 2024, demonstrated resilience despite facing a decline in net income and earnings per share during Q2. The company’s total revenue held steady, indicating its ability to sustain sales in a competitive market. Investors remained confident in PG’s long-term prospects.

Tags: PG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Capitalistic

KBW Analyst Maintains Positive Outlook for Invesco with Revised Price Target

Alternative Energy Stock Market Today

Kinder Morgans Impressive Backlog Dominance in the Natural Gas Market

Telecommunications Industry Stock Exchange

UBS Analyst John Hodulik Maintains Neutral Rating on Verizon Communications with Increased Price Target

Recommended

Abbott Laboratories Stock

Can Abbott’s AI Innovation and Dividend Track Record Propel Its Shares?

3 weeks ago

Empowering the Next Generation enCore Energys Education Society and Scholarship Programs

2 years ago
Synopsys Stock

Synopsys Shares Face Critical Test Amid Legal and Analyst Concerns

2 months ago
Technology Blockchain Trading online

Applied Digital Corporation Announces Disappointing Financial Performance and Decline in Stock Price

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

Yirendai Charts a New Course with Tech-Driven Strategy

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Trending

Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

by Rodolfo Hanigan
February 7, 2026
0

Shares of HBT Financial have recently climbed to a new 52-week peak of $29.37, propelled by a...

Allscripts Healthcare Stock

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Avanos Medical Stock

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • HBT Financial Stock Surges as Strategic Acquisition Nears Completion
  • Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth
  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com